These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 795169)

  • 21. Trimipramine and maprotiline: antidepressant, anxiolytic, and cardiotoxic comparison.
    Pecknold JC; Familamiri P; McClure DJ; Elie R; Chang H
    J Clin Psychiatry; 1985 May; 46(5):166-71. PubMed ID: 2859273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential effects on suicidal ideation of mianserin, maprotiline and amitriptyline.
    Montgomery S; Cronholm B; Asberg M; Montgomery DB
    Br J Clin Pharmacol; 1978; 5 Suppl 1(Suppl 1):77S-80S. PubMed ID: 341948
    [No Abstract]   [Full Text] [Related]  

  • 23. A controlled double-blind clinical trial between maprotiline and amitriptyline in depressive illness.
    Okasha A; Sadek A
    J Egypt Med Assoc; 1976; 59(5-6):557-62. PubMed ID: 801741
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical experience with maprotiline.
    Kabes J; Dostal T; Roth Z
    Act Nerv Super (Praha); 1982 May; 24(2):93-8. PubMed ID: 7048837
    [No Abstract]   [Full Text] [Related]  

  • 25. A comparison of maprotiline (Ludiomil) and slow release amitriptyline (Tryptizol SR).
    McMillin WP
    J Int Med Res; 1977; 5 Suppl 4():51-8. PubMed ID: 590611
    [No Abstract]   [Full Text] [Related]  

  • 26. Maprotiline (Ludiomil) in depression: a report of a monitored release study in general practice.
    Forrest WA
    J Int Med Res; 1977; 5 Suppl 4():112-5. PubMed ID: 590607
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Maprotiline and fluphenazine/nortriptyline in depression.
    O'Hara H; O'Hara J; Valle-Jones JC; McGhie RL; Brodie NH; Schiff AA
    Practitioner; 1978 Sep; 221(1323):419-23. PubMed ID: 366595
    [No Abstract]   [Full Text] [Related]  

  • 28. Efficacy, side-effects, plasma and blood levels of maprotiline (Ludiomil).
    Miller PI; Beaumont G; Seldrup J; John V; Luscombe DK; Jones R
    J Int Med Res; 1977; 5 Suppl 4():101-11. PubMed ID: 590605
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Evaluation of the antidepressive action of maprotiline].
    Bilikiewicz A; Landowski J
    Psychiatr Pol; 1976; 10(4):367-74. PubMed ID: 981412
    [No Abstract]   [Full Text] [Related]  

  • 30. Treatment of depression in outpatients: a controlled comparison of the onset of action of amoxapine and maprotiline.
    Fabre LF
    J Clin Psychiatry; 1985 Dec; 46(12):521-4. PubMed ID: 3905772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A controlled trial of maprotiline (Ludiomil) in depressed outpatients.
    McCallum P; Meares R
    Med J Aust; 1975 Sep; 2(10):392-3. PubMed ID: 1102877
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Symptom reduction in depressed outpatients treated with amitriptyline or maprotiline: repeated measurement analysis.
    Prusoff BA; Weissman MM; Tanner J; Lieb J
    Compr Psychiatry; 1976; 17(6):749-54. PubMed ID: 791572
    [No Abstract]   [Full Text] [Related]  

  • 33. A controlled study of a tetracyclic antidepressant--maprotiline (Ludiomil).
    Kessell A; Holt NF
    Med J Aust; 1975 Jun; 1(25):773-6. PubMed ID: 1097869
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Combined chlorimipramine and maprotiline therapy in therapy-resistant depressions].
    Soucek K
    Act Nerv Super (Praha); 1982 May; 24(2):88-9. PubMed ID: 7102229
    [No Abstract]   [Full Text] [Related]  

  • 35. A comparison of high and low dosage regimes of maprotiline (Ludiomil).
    Donald JF
    J Int Med Res; 1977; 5 Suppl 4():3-10. PubMed ID: 338400
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical and experimental experiences with maprotiline, clomipramine, sydnocarb and mefexamide in mentally-ill patients and in healthy persons].
    Zapletálek M; Hübsch T; Zbytovský J; Polácková J; Kindernayovä H
    Schweiz Arch Neurol Neurochir Psychiatr; 1977; 120(2):323-34. PubMed ID: 333568
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical and electroencephalographic study of a new antidepressive agent, mono-methyl-amino-propyl-dibenzo-bicyclo-octadine hydrochloride (Ciba 34, 276 Ba)].
    Deniker P; Lôo H; Verdeaux G; Oughourlian JM
    Encephale; 1975; 1(3):265-78. PubMed ID: 1227822
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Maprotiline in adult depressed patients. A study of the relation between clinical efficacy and serum concentrations after repeated intravenous and peroral administration.
    Fischbach R
    Arzneimittelforschung; 1979; 29(2):352-5. PubMed ID: 36112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics and efficacy of maprotiline and amitriptyline in endogenous depression: a double-blind controlled trial.
    Montgomery SA; McAuley R; Montgomery DB; Dawling S; Braithwaite RA
    Clin Ther; 1980; 3(4):292-310. PubMed ID: 7023677
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparison of amitriptyline and maprotiline in old depressed patients.
    Koncevoj VA; Andrusenko MP; Pjatnickij AN; Kolibás E; Korinkova V; Mayer A
    Act Nerv Super (Praha); 1989 Jun; 31(2):117-8. PubMed ID: 2800942
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.